ACCS #26, November 2019

The 26th meeting of the Advisory Committee on Chemicals Scheduling (ACCS #26), November 2019.

Date

5 November 2019

A meeting of the Advisory Committee on Chemicals Scheduling (ACCS).

Members

The committee members are professionals with specific scientific, medical or clinical expertise, or expertise in consumer health issues relating to chemicals.

Pre-meeting notice

For the pre-meeting public consultation notice go to:

Consultation: Proposed amendments to the Poisons Standard - ACMS and ACCS, November 2019.

Outcomes

Public submissions on scheduling matters referred to the ACMS #28, ACCS #26 and Joint ACMS-ACCS #23 meetings held in November 2019

25 May 2020

Scheduling submissions

Public submissions on matters referred to the November 2019 scheduling meetings, and received during the interim consultation period
Notice of final decisions to amend (or not amend) the current Poisons Standard, May 2020

7 May 2020

Scheduling decisions (final)

Public notice of the Delegates' final decisions to amend the Poisons Standard
Interim decisions and invitation for further comment on substances referred to the November 2019 ACMS/ACCS meetings

6 February 2020

Scheduling decisions (interim)

Interim decisions and invitation for further comment. Closing date: 5 March 2020

Topics

Meeting of

Advisory Committee on Chemicals Scheduling (ACCS)

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

ACCS #26, November 2019

Members

Pre-meeting notice

Outcomes

Public submissions on scheduling matters referred to the ACMS #28, ACCS #26 and Joint ACMS-ACCS #23 meetings held in November 2019

Notice of final decisions to amend (or not amend) the current Poisons Standard, May 2020

Interim decisions and invitation for further comment on substances referred to the November 2019 ACMS/ACCS meetings

Related content

Sharing information about the safety, quality and performance of medical devices - lunchtime session

Sharing information about the safety, quality and performance of medical devices - evening session